Zobrazeno 1 - 10
of 15
pro vyhledávání: '"William Hsieh"'
Publikováno v:
EJNMMI Radiopharmacy and Chemistry, Vol 8, Iss 1, Pp 1-18 (2023)
Abstract Background Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy which may benefit from radioimmunotherapy. Previously, [177Lu]Lu-DOTA-C595 has been developed as a beta-emitting radioimmunoconjugate to target cancer-specific mu
Externí odkaz:
https://doaj.org/article/d052f7feea314249b9b2145109491896
Publikováno v:
EJNMMI Radiopharmacy and Chemistry, Vol 8, Iss 1, Pp 1-16 (2023)
Abstract Background Pancreatic ductal adenocarcinoma (PDAC) continues to be a malignancy with an unmet clinical demand. Development of radioimmunoconjugates which target cancer-specific receptors provides an opportunity for radioimmunotherapy of both
Externí odkaz:
https://doaj.org/article/0e6a9c6427e044eca543f2af2fff269f
Autor:
Daniel Krafft, Clifton G. Scarboro, William Hsieh, Colleen Doherty, Peter Balint-Kurti, Michael Kudenov
Publikováno v:
Plant Phenomics, Vol 6 (2024)
Automation of plant phenotyping using data from high-dimensional imaging sensors is on the forefront of agricultural research for its potential to improve seasonal yield by monitoring crop health and accelerating breeding programs. A common challenge
Externí odkaz:
https://doaj.org/article/ea829fa486604cee9d31e2713ebbfc95
Autor:
Ashleigh Hull, Yanrui Li, Dylan Bartholomeusz, William Hsieh, William Tieu, Tara L. Pukala, Alexander H. Staudacher, Eva Bezak
Publikováno v:
Cells, Vol 11, Iss 19, p 2983 (2022)
Mucin 1 is a transmembrane glycoprotein which overexpresses cancer-specific epitopes (MUC1-CE) on pancreatic ductal adenocarcinoma (PDAC) cells. As PDAC is a low survival and highly aggressive malignancy, developing radioimmunoconjugates capable of t
Externí odkaz:
https://doaj.org/article/c5b299e7a4b949ae817f2f2c43b6eb11
Autor:
Chuan Ping Tan, Karen Ho, Nam Q. Nguyen, William Hsieh, Dylan Bartholomeusz, Jeevinesh Naidu, Andrew Ruszkiewicz, Joshua Zobel, John W. Chen, Nimit Singhal, Benjamin Crouch, Paul M. Dolan, Romina Safaeian, Deborah Calnan
Publikováno v:
Endoscopy. 54:75-80
Background This study evaluated clinical outcomes of combined chemotherapy and endoscopic ultrasound (EUS)-guided intratumoral radioactive phosphorus-32 (32P) implantation in locally advanced pancreatic adenocarcinoma (LAPC). Methods Consecutive pati
Autor:
William Hsieh, Ashleigh Hull, Yanrui Li, Andrew Ruszkiewicz, Samantha Escarbe, Eva Bezak, Dylan Bartholomeusz
Publikováno v:
Cancers
Volume 13
Issue 1
Cancers, Vol 13, Iss 61, p 61 (2021)
Volume 13
Issue 1
Cancers, Vol 13, Iss 61, p 61 (2021)
Improvements in the prognosis of pancreatic ductal adenocarcinoma (PDAC) rely on the development of effective treatments to target advanced disease. Mucin 1 (MUC1) is a transmembrane glycoprotein which is involved in the metastatic progression of PDA
Radioimmunotherapy of Pancreatic Ductal Adenocarcinoma: A Review of the Current Status of Literature
Publikováno v:
Cancers
Cancers, Vol 12, Iss 2, p 481 (2020)
Cancers, Vol 12, Iss 2, p 481 (2020)
Pancreatic ductal adenocarcinoma (PDAC) has long been associated with low survival rates. A lack of accurate diagnostic tests and limited treatment options contribute to the poor prognosis of PDAC. Radioimmunotherapy using α- or β-emitting radionuc
Autor:
William Hsieh, Chris Tsopelas
Publikováno v:
Journal of Labelled Compounds and Radiopharmaceuticals. 60:528-541
The objective of this study was to investigate the radiosynthesis of 68Ga-Mg-Ca-phytate colloid, and then characterise the formulation for radiochemical purity (RCP), radioactive particle size distribution, and biodistribution in normal rats. This ra
Publikováno v:
Journal of Labelled Compounds and Radiopharmaceuticals. 59:506-516
The objective of this study was to investigate the radiosynthesis of 68 Ga-Ca-phytate particles and then characterize the formulation for radiochemical purity, radioactive particle size distribution, and biodistribution in normal rats. This radiotrac
Publikováno v:
Journal of Labelled Compounds and Radiopharmaceuticals. 58:383-389
The objective of this study was to identify a more rapid assay for (68)Ga(OH)3 impurity in (68)Ga-DOTATATE formulations. Three methods were used to prepare (68)Ga(OH)3 reference material (pharmacopoeial, bench titration and automated radiosynthesis),